Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00567892 · ClinicalTrials.gov registry record · Phase 2

Collaborative Tinnitus Research at Washington University

A Phase 2 study, sponsored by Washington University School of Medicine.

Completed
Registry status
Phase 2
Development phase
55
Enrollment target

NCT00567892 is a Phase 2 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 55 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00567892, a Phase 2 study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Phase 2
Development phase
55 participants
Enrollment target

Study Summary

The goal of this trial to see if repetitive transcranial magnetic stimulation (rTMS) to the hearing area of the brain can lessen the perception of tinnitus. rTMS uses a strong magnet and when placed against the scalp generates a small electrical field within the brain. Depending on the frequency of the stimulation, this electrical field can either decrease or increase the electrical excitability of the brain. In this study, low-frequency stimulation will be used, which is thought to decrease nerve activity. It is this electrical excitability of the brain that is thought to be responsible for tinnitus. The hypothesis of this study is that rTMS can decrease the perception of tinnitus.

Interventions

  • DEVICE rTMS

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2008-01
Est. Completion 2011-06
Phase Phase 2

What the Registry Record Tells You About NCT00567892

The ClinicalTrials.gov registry entry for NCT00567892 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which rTMS is the first listed.

NCT00567892 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00567892 about?

NCT00567892 is a clinical study titled "Collaborative Tinnitus Research at Washington University". The goal of this trial to see if repetitive transcranial magnetic stimulation (rTMS) to the hearing area of the brain can lessen the perception of tinnitus. rTMS uses a strong magnet and when placed against the scalp generates a small electrical field within the brain. Depending on the frequency of ...

What is the current status of trial NCT00567892?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2008-01. Estimated completion is 2011-06.

What interventions are being tested in trial NCT00567892?

The interventions under investigation include: rTMS (DEVICE).

Who is sponsoring clinical trial NCT00567892?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.